Company profile for Bill & Melinda Gates Foundation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunitie...
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and Melinda French Gates.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
500 5th Ave North, Seattle, WA 98109
Telephone
Telephone
(206) 709-3400
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/ghit-backed-innovation-achieves-landmark-new-treatment-option-for-schistosomiasis-reaches-preschool-aged-children-302391944.html

PR NEWSWIRE
04 Mar 2025

https://www.globenewswire.com/news-release/2025/01/07/3005212/0/en/Micron-Biomedical-Secures-43-Million-in-Total-Grant-Support-to-Improve-Coverage-of-Measles-and-Rubella-Vaccine-and-Accelerate-World-s-First-Phase-2-Trial-of-Needle-Free-Drug-and-Va.html

GLOBENEWSWIRE
07 Jan 2025

https://www.prnewswire.com/news-releases/new-alliance-for-the-development-of-a-sublingual-oxytocin-formulation-to-prevent-postpartum-hemorrhage-302311613.html

PR NEWSWIRE
21 Nov 2024

https://www.businesswire.com/news/home/20241029589496/en

BUSINESSWIRE
30 Oct 2024

https://www.forbes.com/sites/roberthart/2024/05/06/gates-novo-nordisk-and-wellcome-commit-300-million-to-climate-change-infectious-diseases-and-nutrition/?sh=7d8660ac15c7

Robert Hart FORBES
07 May 2024

https://www.businesswire.com/news/home/20240319141319/en

BUSINESSWIRE
19 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty